Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma

References

• PruthiDKOomahSLuVQuality and quantity in kidney cancer surgery: the role of nonneoplastic kidney and kidney volumetrics in predicting postoperative renal functionAm J Clin Pathol2019151110811530212840
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• CindoloLPatardJ-JChiodiniPComparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European studyCancer200510471362137116116599
   PubMed Web of Science ®Google Scholar
• CalvoESchmidingerMHengDYCGrünwaldVEscudierBImprovement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapyCancer Treat Rev20165010911727664394
   PubMed Web of Science ®Google Scholar
• HengDYMackenzieMJVaishampayanUNPrimary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyAnn Oncol20122361549155522056973
   PubMed Web of Science ®Google Scholar
• FardiniYDehennautVLefebvreTIssadTO-GlcNAcylation: a new cancer hallmark?Front Endocrinol2013499
   PubMed Web of Science ®Google Scholar
• TrincaGMGoodmanMLPapachristouEKO-GlcNAc-Dependent regulation of progesterone receptor function in breast cancerHorm Canc2018911221
   PubMed Web of Science ®Google Scholar
• OzcanSAndraliSSCantrellJELModulation of transcription factor function by O-GlcNAc modificationBiochim Biophys Acta201017995–635336420202486
   PubMed Web of Science ®Google Scholar
• MaZVossellerKCancer metabolism and elevated O-GlcNAc in oncogenic signalingJ Biol Chem201428950344573446525336642
   PubMed Web of Science ®Google Scholar
• MaZVocadloDJVossellerKHyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cellsJ Biol Chem201328821151211513023592772
   PubMed Web of Science ®Google Scholar
• HartGWHousleyMPSlawsonCCycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteinsNature200744671391017102217460662
   PubMed Web of Science ®Google Scholar
• YangWHKimJENamHWModification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stabilityNat Cell Biol20068101074108316964247
   PubMed Web of Science ®Google Scholar
• YangWHParkSYNamHWNFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditionsProc Natl Acad Sci U S A200810545173451735018988733
   PubMed Web of Science ®Google Scholar
• GuYMiWGeYGlcNAcylation plays an essential role in breast cancer metastasisCancer Res201070156344635120610629
   PubMed Web of Science ®Google Scholar
• LynchTPFerrerCMJacksonSRShahriariKSVossellerKReginatoMJCritical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasisJ Biol Chem201228714110701108122275356
   PubMed Web of Science ®Google Scholar
• MiWGuYHanCO-GlcNAcylation is a novel regulator of lung and colon cancer malignancyBiochim Biophys Acta20111812451451921255644
   PubMed Web of Science ®Google Scholar
• ZhuQZhouLYangZO-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantationMed Oncol201229298599321461968
   PubMed Web of Science ®Google Scholar
• DingXJiangWZhouPMixed lineage leukemia 5 (MLL5) protein stability is cooperatively regulated by O-GlcNAc transferase (OGT) and ubiquitin specific protease 7 (USP7)PLoS One20151012e014502326678539
   PubMed Web of Science ®Google Scholar
• ShiYTomicJWenFAberrant O-GlcNAcylation characterizes chronic lymphocytic leukemiaLeukemia20102491588159820668475
   PubMed Web of Science ®Google Scholar
• MendelsohnJAntibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinicCancer Immunol Immunother200352534234612700950
   PubMed Web of Science ®Google Scholar
• UhlmanDLNguyenPManivelJCEpidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosisClin Cancer Res1995189139209816062
   PubMed Web of Science ®Google Scholar
• HofmockelGRiessSBassukasIDDämmrichJEpidermal growth factor family and renal cell carcinoma: expression and prognostic impactEur Urol19973144784849187911
   PubMed Web of Science ®Google Scholar
• MochHSauterGBuchholzNEpidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinomaHum Pathol19972811125512599385930
   PubMed Web of Science ®Google Scholar
• KallioJPHirvikoskiPHelinHMembranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinomaBr J Cancer20038971266126914520458
   PubMed Web of Science ®Google Scholar
• LeQ-TDenkoNCGiacciaAJHypoxic gene expression and metastasisCancer Metastasis Rev2004233–429331015197330
   PubMed Web of Science ®Google Scholar
• YangJCBevacizumab for patients with metastatic renal cancer: an updateClin Cancer Res20041018 Pt 26367S6370S15448032
   PubMed Web of Science ®Google Scholar
• MotzerRJMichaelsonMDRedmanBGActivity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaJ Clin Oncol2006241162416330672
   PubMed Web of Science ®Google Scholar
• RatainMJEisenTStadlerWMPhase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinomaJ Clin Oncol200624162505251216636341
   PubMed Web of Science ®Google Scholar
• ItkonenHMMinnerSGuldvikIJO-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-myc in human prostate cancer cellsCancer Res201373165277528723720054
   PubMed Web of Science ®Google Scholar
• ItkonenHMGoradSSDuveauDYInhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolismOncotarget2016711124641247626824323
   PubMedGoogle Scholar
• StatevaSRVillaloboAO-GlcNAcylation of the human epidermal growth factor receptorOrg Biomol Chem201513308196820426108188
   PubMed Web of Science ®Google Scholar
• DorđevićGMatušan IlijašKHadžisejdićIMaričićAGrahovacBJonjićNEGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinomaJ Biomed Sci20121914022475688
   PubMed Web of Science ®Google Scholar
• MerseburgerASHennenlotterJSimonPMembranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancerAnticancer Res2005253B1901190716158924
   PubMed Web of Science ®Google Scholar
• DossusLKaaksRNutrition, metabolic factors and cancer riskBest Pract Res Clin Endocrinol Metab200822455157118971118
   PubMed Web of Science ®Google Scholar
• RobertsDLDiveCRenehanAGBiological mechanisms linking obesity and cancer risk: new perspectivesAnnu Rev Med201061130131619824817
   PubMedGoogle Scholar
• HartGWCopelandRJGlycomics hits the big timeCell2010143567267621111227
   PubMed Web of Science ®Google Scholar
• SlawsonCPidalaJPotterRIncreased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetyl-glucosamine containing proteinsBiochim Biophys Acta20011537214715711566258
   PubMed Web of Science ®Google Scholar
• KrześlakAFormaEBernaciakMRomanowiczHBryśMGene expression of O-GlcNAc cycling enzymes in human breast cancersClin Exp Med2012121616521567137
   PubMed Web of Science ®Google Scholar
• KrześlakAWójcik-KrowirandaKFormaEBieńkiewiczABryśMExpression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlationsGinekol Pol2012831222622384635
   PubMed Web of Science ®Google Scholar
• LôrinczTTímárJSzendrôiMAlterations of microvascular density in bone metastases of adenocarcinomasPathol Oncol Res200410314915315448750
   PubMed Web of Science ®Google Scholar
• PantuckAJZengGBelldegrunASFiglinRAPathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathwayClin Cancer Res20039134641465214581333
   PubMed Web of Science ®Google Scholar
• RiniBISmallEJBiology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinomaJ Clin Oncol20052351028104315534359
   PubMed Web of Science ®Google Scholar
• LuZJiangGBlume-JensenPHunterTEpidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinaseMol Cell Biol200121124016403111359909
   PubMed Web of Science ®Google Scholar
• DiJHGaoKYQuDBYangJZhengJNRap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinomaTumor Biol20173971010428317701653
   Google Scholar
• LiuFShangliZHuZCAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathwayOncotargets Ther20181162096216
   PubMed Web of Science ®Google Scholar